A detailed history of Elequin Capital LP transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Elequin Capital LP holds 121 shares of TNDM stock, worth $4,358. This represents 0.0% of its overall portfolio holdings.

Number of Shares
121
Holding current value
$4,358
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$35.21 - $47.3 $4,260 - $5,723
121 New
121 $5,000
Q3 2023

Nov 14, 2023

SELL
$19.33 - $36.22 $309 - $579
-16 Reduced 94.12%
1 $0
Q2 2023

Aug 14, 2023

BUY
$24.18 - $42.46 $411 - $721
17 New
17 $0
Q2 2022

Aug 11, 2022

SELL
$53.22 - $123.09 $798 - $1,846
-15 Reduced 62.5%
9 $1,000
Q1 2022

May 16, 2022

BUY
$101.89 - $150.09 $713 - $1,050
7 Added 41.18%
24 $3,000
Q4 2021

Feb 15, 2022

BUY
$118.18 - $153.21 $2,009 - $2,604
17 New
17 $3,000

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.31B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Elequin Capital LP Portfolio

Follow Elequin Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elequin Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Elequin Capital LP with notifications on news.